Skip to main content

ASTHMA-Etiology, Pathogenesis, Clinical Presentation, Diagnosis & Treatment!

 ASTHMA

Definition:

According to WHO:

"It is a disease characterized by recurring attacks of breathlessness and wheezing which vary in frequency according to the nature of allergen and these symptoms vary from hour to hour or day to day".

According to Principle & Practice of Medicines by Davidson:

"It is chronic inflammatory disorder of airways associated with airway hyper-responsiveness that leads to recurrent episodes of wheezing, breathlessness or coughing particularly at night or early in the morning".

Etiology:

  • Hyperresponsiveness-exaggerated response of airway to any non-specific stimulus which results in airway obstruction.
  • Broncho-constriction- Breathlessness or spasm due to construction of bronchioles in airway stimulus.


Allergens:

  1. Industrial chemicals such as paints, hairsprays or resins
  2. Drugs such as NSAIDs, Beta-blockers
  3. Food products such as dairy products, fish, etc.
  4. Environmental pollutants such as cigarette, smoke
  5. Industrial triggers such as wood
  6. Miscellaneous


Pathophysiology:

  • Hypersensitivity Type-1
  • Atopy- genetic tendency
  • Allergy
  • Platelet activating factors (PAF)

  1. Extrinsic allergens (common in children) or Intrinsic non-allergens (triggered by non-allergen factors such as excessive exercise or other factors except allergens, cause inflammation due to either presence of eosinophils or absence of eosinophils.
  2. Mast cells release antibodies as a result of IgE immediate response (Histamine, Prostaglandin generating factors, Bradykinin, Macrophages, Platelet Activating factors (PAF)

*The PAF are produced by the macrophages which cause hyper-responsiveness and release plasma into bronchial cavity leading to hypertrophy*.

       3. Mucosal cells increase mucosal secretion resulting in wheezing, hypercapnia (CO2 not being exhaled).

Clinical Presentation

  • persistent cough (Most common symptom)
  • Difficulty breathing associated with wheezing.
  • Increased pulse rate (110beats/min)
  • Heart rate (90 beats/min)
  • PFR 100L/min
  • Saturated oxygen level is reduced to < 92%
  • Hypercapnia (increased C02)
*Arterial Blood Gas test (ABG) detects all these changes*.


Investigation

FEV1: 

Force Expiratory volume in 1 second. This is used for the measurement of exhalation (how much we exhale in 1 second)

FVC:

Force Vital Capacity Detects maximum exhalation. Spirometer is used for this purpose.

FEV/FVC ratio should always be greater than 0.7%




Peak Flow Meter (PF Meter): 

This apparatus can be used by the patient itself at home. It checks the flow rate and also the prognosis i.e, either asthma is controlled or not.


Diagnosis:

  • Global Initiative for Asthma control (GINA) states that the diagnosis of asthma can be confirmed with response to bronchodilators and examine the patient variation in peak expiration rate (PEFR) day to day. If there is a diagonal (24hr) variability of 60L/min or more than 20% is highly suggestive for asthma diagnosis.


Treatment:

  • Treatment for chronic asthma according to BTS/SIGN Guidelines include Reliever ( SABA) and Controller/Preventer (Steroids)
  1. Inhale reliever as required (2-4 puffs repeated every 4hrs).
  2. Patient took reliever and is not recovered, so the patient is moved to controllers. Dose recommended is 200-800microgram/day to 400microgram/day. Start the dose of Inhaled Corticosteroids (ICS) according to severity.
  3. Additional add-on therapy:
  • Add LABA. Inhale long acting B2 agonist.
  • Now access the response. If good response, continue. If benefits from LABA but control is still inadequate, continue LABA but increase dose up to 800mg/day. (If not use the same dose).
  • If no response to LABA, stop LABA and increase the dose of ICS. Use the trial of other drugs or sustain release theophylline or leukotriene.
  • Persistent poor control. Increase the dose of ICS upto 200microgram/day and addition of the 4th drug b2 agonist (Salbutamol orally).
  • Continuous or frequently use of oral corticosteroids (OCS). Use daily steroid tablets in lowest dose. Maintain high dose of ICS (200 microgram/day). Consider other tablets to minimize use of steroid tablets.
  • Specialized care to the patients.
Labels:

Comments

Post a Comment

Popular posts from this blog

Procedure of IV selection!

 IV DRUG THERAPY- SELECTION OF EQUIPMENTS AND INSERTION OF CATHETER Equipment: Canula selection: Select cannula based on purpose and duration of use and age of patient. Consider risk of infection and extravasation. Cannula made from polyurethanes are associated with decreased risk of phlebitis. Steel needles have higher risk of extravasation and should be avoided where tissue necrosis is likely if extravasation occurs.       2. Skin Prep: Antiseptic solution, use an aqueous based alternative if there is a known allergy to alcohol.       3. Other Equipment: Intravenous solution as ordered, torniquet, giving set, IV stand/pole, infusion pump, transparent occlusive dressing, tape or similar to secure cannula, gloves, paper bag.       4. Additional Equipment which may be required: Syring (5mL), sterile sodium chloride 0.9%, local anesthetics (in children), 3-way tap or triflow, short extension tube. Selection Of the Catheter Site: Generally ...
Post a Comment
Read more

General Mechanism of Actions of INSULIN.

GENERAL MECHANISM OF ACTION OF INSULIN AND RELATE HORMONES The body's main fuel is Glucose. Glucose is stored in the liver and muscles as Glycogen.  Excess glucose is stored in the adipose tissues which yield fatty acids via lipolysis. In the fasting state, free fatty acids supply much of the energy needs of the body except for the CNS which requires Glucose to function normally. Proteins can also be converted to glucose via gluconeogenesis. RELEASE OF INSULIN AND GLUCAGON Insulin and Glucagon are produced in the pancreas by the Islets of Langerhans . Beta cells   make up 70%-90% of the Islets and produce Insulin and Amylin while the a-cells   produce glucagon. The main function of insulin is to decrease blood glucose levels. Glucagon, along with other counter-regulatory hormones such as growth factor, cortisol, and Epinephrine, increases Blood glucose levels.  The opposing actions of Glucagon and Insulin along with other counter-regulatory hormones maintain a norma...
Post a Comment
Read more

Diabetes Mellitus: Clinical Presentation and Diagnosis!

 CLINICAL PRESENTATION AND DIAGNOSIS OF DM 2. SCREENING American Diabetes Association (ADA) recommends routine screening for T2 DM every 3 years in all adults starting at 45 years of age. Testing of T2 DM should be considered in any adult, regardless of their age, who have a BMI greater than or equal to 25kg/m2. The ADA does not currently recommend widespread screening for T1 DM because of the relatively low incidence in the general population, although measurement of Islet antibodies may be appropriate for high-risk individuals. 3.GESTATIONAL DIABETES: "Gestational diabetes is the glucose intolerance in women during pregnancy". All pregnant women who have risk factors for T2 DM should be screened for undiagnosed T2 DM at their first prenatal visit using standard diagnostic criteria.  Any women found to have diabetes in the early point at pregnancy is considered to have T2 DM or GDM. All other pregnant women, not currently known to have DM should be screened for GDM with a 75...
Post a Comment
Read more